FGFR2 and Apert syndrome: Our Apert syndrome mouse models are heterozygotes, so cells expressing Fgfr2 receptors have both normal and mutant receptors, the latter of which lead to aberrant Fgfr2 activation by modifying ligand affinity and specificity [5].